James M. Gower
2011
In 2011, James M. Gower earned a total compensation of $1.4M as Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 43% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $467,208 |
|---|---|
| Option Awards | $322,082 |
| Salary | $648,900 |
| Other | $5,148 |
| Total | $1,443,338 |
Gower received $648.9K in salary, accounting for 45% of the total pay in 2011.
Gower also received $467.2K in non-equity incentive plan, $322.1K in option awards and $5.1K in other compensation.
Rankings
In 2011, James M. Gower's compensation ranked 4,354th out of 10,747 executives tracked by ExecPay. In other words, Gower earned more than 59.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,354 out of 10,747 | 60th |
Division Manufacturing | 1,545 out of 3,960 | 61st |
Major group Chemicals And Allied Products | 316 out of 1,033 | 69th |
Industry group Drugs | 187 out of 781 | 76th |
Industry Pharmaceutical Preparations | 145 out of 571 | 75th |
Source: SEC filing on April 8, 2014.
Gower's colleagues
We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2011.
2011
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2011
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2011
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2011
Ryan Maynard
Rigel Pharmaceuticals